4Life® Transfer Factor™ Now
Approved By the Health
Ministry of Russia for use in Hospitals and Clinics!
First Ever Dietary Supplement to be
Approved for Use by Doctors and Hospitals in Russia
SANDY, UT (October 1, 2004) - In
an unprecedented announcement in the history of network marketing,
4Life announced today that
4Life Transfer Factor products as immune modulators have been
approved for use in hospitals and clinics in the Russian Federation.
The results of ten separate clinical trials and two experimental
studies on 4Life Transfer Factor products were combined in a
Methodological Document that was approved by the Ministry of
Health, which now allows doctors to recommend 4Life Transfer
Factor Classic and 4Life Transfer Factor Plus® products to
their patients.
First Dietary Supplement Approved for Use by Doctors and Hospitals
in Russia
Commenting on this remarkable achievement, David Lisonbee, CEO
of 4Life stated, “To my knowledge, this is the first time
in the history of this industry that a network marketing company
or any other dietary supplement company has had one of its dietary
supplements approved for use in hospitals in Russia. The Russian
Ministry of Health is the equivalent of the Food and Drug Administration
in the United States. Doctors and scientists from Russia have
been working jointly with scientists from 4Life for several years
to arrive at this accomplishment. This approval establishes a
new roll of dietary supplements in the Russian health care system.
Remarkable Response from Russian Academy of Medical Sciences
In another sector of research of 4Life Transfer Factor, Dr. Kisielevsky
of the Russian Academy of Medical Sciences stated, “The
4Life sample [Transfer Factor Advanced Formula] activated NK
(natural killer) cell activity more than the Interleukin-2
(IL2) drug we used as the standard.” This discovery has
attracted the attention of The International Scientific and
Technical Center (ISTC) of Russia.
Scientists from Several Countries Join Forces for Additional
Clinical Studies of Transfer Factor
The ISTC of Russia is a member of a joint international project
with other health agencies of Japan, Europe and the US. The objective
of the international project is to combine efforts in finding
improved immunotherapies. Following the discoveries from the
NK cell testing, the scientists of 4Life have been invited to
join the project. 4Life Transfer Factor as an immune modulator
will be further researched in this international forum. The cost
of the studies will be paid by the ISTC.
Worldwide Ramification
Speaking of this benchmark achievement, Dr.
Calvin McCausland, VP of Research of 4Life, and Dr. Emma Oganova,
4Life/Eurasia
President, jointly expressed that because of the acceptance
by such a reputable organization and doctors from Russia and
other major countries, 4Life Transfer Factor will gain wider
acceptance in the professional and private sectors as a superior
immune system enhancing product. The worldwide ramifications
to this acceptance are just beginning.
4Life is the world’s foremost
leader in the development, production and distribution of natural
immune support products
and was recently recognized by Inc. magazine as the fifteenth
fastest growing privately-held company in America.
View
Abstract
Transfer
Factor Cardio and
Transfer Factor Plus Listed in
Physicians Desk Reference
View
Graph
For
more information on any of 4Life’s™ products, please
feel free to contact us. Use your back button to return
to the homepage or newsletter that contains our contact information.
If you have any questions or need assistance with ordering,
we are pleased to help you in any way we can.
